In your opinion, what is the most important risk associated with 5-aminosalicylate therapy in patients with inflammatory bowel disease? Let us know by taking the poll!
In your opinion, what is the most important risk associated with 5-aminosalicylate therapy in patients with inflammatory bowel disease? Let us know by taking the poll!
Listen to our podcast with Dr Stefan Holubar from Cleveland Clinic on managing inflammatory bowel disease and malignancy. Then, take this quiz to see what you have learned.